ARENA PHARMACEUTICALS INC Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018	FY2017 12 months to Dec 31, 2017
Operating activities:
Net income (loss)
Net (loss) income
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Loss from discontinued operations
Acquired in-process research and development
Depreciation and amortization
Deferred income taxes
Non-cash collaboration revenue
Non-cash royalty revenue
Share-based compensation
Litigation settlement expense, net
Gain on deconsolidation of Longboard
Amortization of prepaid financing costs
Gain from Longboard equity method investment
Amortization of original issue discounts, net of premiums, on available- for-sale investments
Loss (gain) on disposal of property and equipment
Other operating activities, net

Changes in operating assets and liabilities:
Accounts receivable
Prepaid expenses and other assets
Accounts payable, accrued clinical and other current liabilities
Accrued litigation settlement
Deferred revenues
Deferred rent
Other long-term liabilities
Net cash (used in) provided by operating activities - continuing operations
Net cash used in operating activities - discontinued operations

Net cash (used in) provided by operating activities - continuing operations
Investing activities:
Purchases of available-for-sale securities, net
Cash paid for acquired in-process research and development
Purchases of available-for-sale investments
Proceeds from sale and maturity of available-for-sale investments
Deconsolidation of variable interest entity
Purchases of property and equipment
Proceeds from sale of property and equipment
Other non-current assets
Net cash provided by (used in) investing activities - continuing operations
Net cash provided by investing activities - discontinued operations
Net cash provided by (used in) investing activities

Financing activities:
Principal payments on lease financing obligations
Proceeds from issuance of common stock under ATM facility, net
Proceeds from issuance of common stock in public offering, net
Proceeds from issuance of common stock from stock plans, net
Net cash provided by financing activities
Net decrease in cash and cash equivalents
Cash and cash equivalents at beginning of year
Cash and cash equivalents at end of year
Effect of exchange rate changes on cash
Net increase in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at beginning of year
Cash, cash equivalents and restricted cash at end of year
Supplemental disclosure of cash flow information:
Interest paid
Disposition of property and land upon lease expiration
Reduction in lease financing obligation from release of residual value upon lease expiration

Comments